Showing results (111-120 of 259) with videos related to

Sort By:
Pageof 26
Alzheimer'S Research & Therapy|June 26, 2025
The economic burden of subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia: excess costs and associated clinical and risk factorsEva Gläser, Ingo Kilimann, Moritz Platen, et al.
JCI Insight|April 10, 2020
Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptorsPaul Dembny, Andrew G Newman, Manvendra Singh, et al.
Nature Neuroscience|May 22, 2012
An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegenerationSabrina M Lehmann, Christina Krüger, Boyoun Park, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthEva Glaeser, Ingo Kilimann, Moritz Platen, et al.
Genome Medicine|July 19, 2023
A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's diseaseAnnett Boeddrich, Christian Haenig, Nancy Neuendorf, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 11, 2022
Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementiaLuca Kleineidam, Michael Wagner, Jannis Guski, et al.
Annals of Clinical and Translational Neurology|May 4, 2026
Impact of Plasma p-tau181 on Cognition, Motor Phenotypes, and Disease Course in ALSElisabeth Kasper, Annaliis Lehto, Nina Nordmann, et al.
Stroke|November 26, 2011
Genome-wide association study of vascular dementiaElisabeth M C Schrijvers, Britta Schürmann, Peter J Koudstaal, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 9, 2025
"The DESCRIBE-ALS-FTD study: a prospective multicenter observational study of the ALS-FTD spectrum"Andreas Hermann, Johannes Prudlo, Elisabeth Kasper, et al.
International Journal of Molecular Sciences|December 11, 2022
Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear PalsyFabio A Simoes, Greig Joilin, Oliver Peters, et al.
Pageof 26